NeuroOne Medical Technologies, headquartered in Eden Prairie, Minnesota, develops thin film electrode technology for neurodiagnostic and treatment solutions, focusing on conditions like epilepsy and chronic pain. The company went public on November 9, 2012, and employs 16 people.
NeuroOne Medical Technologies (NMTC) reported a positive EPS surprise in its most recent quarterly earnings. For the most recent quarter, NeuroOne Medical Technologies's actual EPS was -$0.07, beating the estimate of -$0.09 per share, resulting in a 23.75% surprise.
📡️ Health Care
Earnings Surprise
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
